Invention Grant
- Patent Title: Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
-
Application No.: US13409506Application Date: 2012-03-01
-
Publication No.: US08575192B2Publication Date: 2013-11-05
- Inventor: Daniel Marquess , Paul R. Fatheree , S. Derek Turner , Daniel D. Long
- Applicant: Daniel Marquess , Paul R. Fatheree , S. Derek Turner , Daniel D. Long
- Applicant Address: US CA South San Francisco
- Assignee: Theravance, Inc.
- Current Assignee: Theravance, Inc.
- Current Assignee Address: US CA South San Francisco
- Agent Jeffrey A. Hagenah; Roberta P. Saxon
- Main IPC: A61K31/439
- IPC: A61K31/439 ; A61P1/00
Abstract:
The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
Public/Granted literature
- US20120264779A1 QUINOLINONE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS Public/Granted day:2012-10-18
Information query
IPC分类:
